|
Real-time Estimate
Cboe Europe
16:18:15 17/04/2026 BST
|
5-day change
|
1st Jan Change
|
|
2,137.50 GBX
|
+0.68%
|
 |
-2.16%
|
+16.69%
|
|
04-13 |
NRx Pharmaceuticals, Inc. Announces Appointment of Glenn Tyson as Chief Commercial Officer
|
CI
| |
04-09 |
Medicenna Therapeutics Corp. Appoints Nageatte Ibrahim as Chief Medical Officer
|
CI
| |
04-09 |
Idorsia Ltd Announces Executive Changes
|
CI
| |
03-24 |
GSK, Smiths Group and Savills directors buys shares
|
AN
| |
03-17 |
Bicycle Therapeutics plc Announces Executive Changes, Effective March 12, 2026
|
CI
| |
03-13 |
Global markets live: Apple, Amazon, Nvidia, Uber, Adobe…
|  | |
03-10 |
Santhera Pharmaceuticals Announces Executive Changes
|
CI
| |
03-09 |
Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
| | |
03-09 |
GSK plc Appoints Elizabeth McKee Anderson as Member of the Corporate Responsibility Committee, Effective March 9, 2026
|
CI
| |
03-09 |
Spruce Biosciences Appoints Dale Hooks as Chief Commercial Officer, Effective March 9, 2026
|
CI
| |
02-20 |
GSK non-executive director buys nearly GBP75,000 in shares
|
AN
| |
02-17 |
Berenberg Says GSK 'Best Performer' in Pharmaceutical Sector; Price Target Up
|
MT
| |
02-13 |
NatWest results ahead of forecasts, ups dividend 51%
|
AN
| |
02-13 |
Sanofi's new CEO needs to fix drug pipeline and navigate Trump
|
RE
| |
02-12 |
Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
|
RE
| |
02-12 |
Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
|
RE
| |
02-06 |
GSK Chair Jonathan Symonds buys GBP53,000 in shares
|
AN
| |
02-04 |
GSK optimistic for 2026 after fourth-quarter results beat forecast
|
AN
| |
02-04 |
GSK's Specialty Medicines Drive Solid Results
|
DJ
| |
02-04 |
GSK forecasts slower sales growth in 2026
|
RE
| |
02-04 |
GSK eyes sharper, faster drug development as new CEO signals growth plan
|
RE
| |
02-02 |
GSK cutting jobs in UK and US as part of ongoing R&D changes
|
AN
| |
01-30 |
Immunocore Holdings plc Announces Executive Changes
|
CI
| |
01-28 |
Omass Therapeutics Announces Board Changes
|
CI
| |
01-09 |
Croda International plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
